{
  "_link": {
    "uuid": "lp-7bb5ef16-9645-b119-bb5f-a1c10ae19592",
    "version": 1,
    "contentHash": "hash-7bb5ef16",
    "title": "I can evaluate the use of radioisotopes in medical diagnosis and therapy",
    "generatedAt": "2026-01-26T18:00:00Z"
  },
  "toLevel2": [
    {
      "type": "mc",
      "question": "What type of radiation is preferred for medical imaging and diagnosis?",
      "correct": "Gamma radiation",
      "correctExplanation": "Gamma rays can exit the body to be detected by external cameras, making them ideal for imaging internal organs.",
      "distractors": [
        { "answer": "Alpha radiation", "explanation": "Alpha particles cannot exit the body and would not reach external detectors." },
        { "answer": "Beta radiation", "explanation": "Beta particles have limited ability to exit the body for external imaging." },
        { "answer": "Neutron radiation", "explanation": "Neutrons are not typically used for diagnostic medical imaging." }
      ]
    },
    {
      "type": "mc",
      "question": "Which radioisotope is commonly used for diagnostic imaging of many organs?",
      "correct": "Technetium-99m",
      "correctExplanation": "Technetium-99m is a gamma emitter with a 6-hour half-life, making it ideal for diagnostic imaging.",
      "distractors": [
        { "answer": "Uranium-238", "explanation": "Uranium-238 has too long a half-life and is not suitable for medical use." },
        { "answer": "Plutonium-239", "explanation": "Plutonium is highly toxic and not used in medical diagnosis." },
        { "answer": "Radium-226", "explanation": "Radium has too long a half-life and emits alpha particles, making it unsuitable for diagnosis." }
      ]
    },
    {
      "type": "mc",
      "question": "Why are short half-lives preferred for diagnostic radioisotopes?",
      "correct": "To minimise radiation exposure to the patient after the scan",
      "correctExplanation": "Short half-lives mean the radioactivity decreases quickly, reducing the total dose to the patient.",
      "distractors": [
        { "answer": "To make the images clearer", "explanation": "Image quality depends on gamma energy and detector technology, not half-life." },
        { "answer": "To make the isotopes easier to produce", "explanation": "Short half-lives actually make production and transport more challenging." },
        { "answer": "To increase the penetrating power of the radiation", "explanation": "Penetrating power depends on radiation type and energy, not half-life." }
      ]
    },
    {
      "type": "mc",
      "question": "What is the main purpose of radiotherapy?",
      "correct": "To destroy cancer cells with targeted radiation",
      "correctExplanation": "Radiotherapy delivers radiation doses to tumours to kill cancer cells while minimising damage to healthy tissue.",
      "distractors": [
        { "answer": "To create images of internal organs", "explanation": "That is the purpose of diagnostic imaging, not therapy." },
        { "answer": "To measure the activity of the thyroid gland", "explanation": "That is a diagnostic application, not a therapeutic one." },
        { "answer": "To detect bone fractures", "explanation": "Bone imaging is diagnostic; therapy aims to treat disease." }
      ]
    },
    {
      "type": "mc",
      "question": "Iodine-131 is used to treat thyroid cancer. Why does it target thyroid tissue?",
      "correct": "The thyroid gland naturally absorbs iodine from the bloodstream",
      "correctExplanation": "The thyroid concentrates iodine for hormone production, so radioiodine accumulates there selectively.",
      "distractors": [
        { "answer": "Iodine-131 has a special affinity for cancer cells only", "explanation": "Iodine is absorbed by all thyroid tissue, not just cancer cells." },
        { "answer": "The radiation from iodine-131 is attracted to the thyroid", "explanation": "Radiation doesn't have chemical affinity; the iodine atom is what's absorbed." },
        { "answer": "Doctors inject it directly into the thyroid gland", "explanation": "Radioiodine is usually taken orally or by injection into the bloodstream." }
      ]
    },
    {
      "type": "tf",
      "question": "Gamma-emitting isotopes are preferred for medical imaging because the radiation can exit the body.",
      "correct": "True",
      "correctExplanation": "Gamma rays have high penetrating power, allowing them to escape the body and be detected by external cameras.",
      "distractors": [
        { "answer": "False", "explanation": "Students may confuse imaging requirements with therapy requirements." }
      ]
    },
    {
      "type": "tf",
      "question": "The same radioisotope is always used for both diagnosis and treatment of thyroid conditions.",
      "correct": "False",
      "correctExplanation": "Different isotopes serve different purposes: iodine-123 (gamma) for diagnosis, iodine-131 (beta) for treatment.",
      "distractors": [
        { "answer": "True", "explanation": "Students may not realise different radiation properties suit different medical applications." }
      ]
    },
    {
      "type": "cloze",
      "prompt": "Complete the sentence about diagnostic imaging.",
      "sentence": "Medical imaging uses {{blank:1}} emitters because this type of radiation can {{blank:2}} the body to reach external detectors.",
      "blanks": {
        "1": {
          "correct": "gamma",
          "correctExplanation": "Gamma radiation's high penetrating power allows it to exit the body for detection.",
          "distractors": [
            { "answer": "alpha", "explanation": "Alpha particles cannot exit the body and are unsuitable for imaging." },
            { "answer": "beta", "explanation": "Beta particles have limited ability to exit for external imaging." }
          ]
        },
        "2": {
          "correct": "exit",
          "correctExplanation": "The radiation must leave the body to be captured by imaging equipment.",
          "distractors": [
            { "answer": "heat", "explanation": "Heating is not the mechanism for medical imaging." },
            { "answer": "damage", "explanation": "While some damage occurs, the purpose is detection, not damage." }
          ]
        }
      }
    },
    {
      "type": "cloze",
      "prompt": "Complete the sentence about radiotherapy.",
      "sentence": "Radiotherapy aims to {{blank:1}} cancer cells while minimising damage to {{blank:2}} tissue.",
      "blanks": {
        "1": {
          "correct": "destroy",
          "correctExplanation": "The therapeutic goal is to kill cancer cells with radiation.",
          "distractors": [
            { "answer": "image", "explanation": "Imaging is for diagnosis; therapy aims to destroy cancer." },
            { "answer": "detect", "explanation": "Detection is for diagnosis; therapy aims to treat." }
          ]
        },
        "2": {
          "correct": "healthy",
          "correctExplanation": "Minimising damage to surrounding healthy tissue is a key goal of radiotherapy.",
          "distractors": [
            { "answer": "cancerous", "explanation": "Damage to cancerous tissue is the goal, not something to minimise." },
            { "answer": "all", "explanation": "The goal is to target cancer while sparing healthy tissue." }
          ]
        }
      }
    },
    {
      "type": "cloze",
      "prompt": "Complete the sentence about iodine radioisotopes.",
      "sentence": "Iodine-123 is used for thyroid {{blank:1}}, while iodine-131 is used for thyroid {{blank:2}}.",
      "blanks": {
        "1": {
          "correct": "diagnosis",
          "correctExplanation": "Iodine-123 is a gamma emitter suitable for imaging thyroid function.",
          "distractors": [
            { "answer": "treatment", "explanation": "Iodine-131, not iodine-123, is used for treatment." },
            { "answer": "removal", "explanation": "Surgical removal is different from radioisotope diagnosis." }
          ]
        },
        "2": {
          "correct": "treatment",
          "correctExplanation": "Iodine-131 emits beta radiation that destroys thyroid tissue.",
          "distractors": [
            { "answer": "diagnosis", "explanation": "Iodine-123, not iodine-131, is typically used for diagnosis." },
            { "answer": "imaging", "explanation": "Imaging uses gamma emitters; iodine-131's beta is for therapy." }
          ]
        }
      }
    }
  ],
  "toLevel3": [
    {
      "type": "mc",
      "question": "Why is technetium-99m particularly suitable for diagnostic imaging?",
      "correct": "It emits gamma rays and has a short 6-hour half-life",
      "correctExplanation": "The gamma emission allows external detection, and the short half-life minimises patient radiation exposure.",
      "distractors": [
        { "answer": "It emits alpha particles that create clear images", "explanation": "Tc-99m emits gamma rays, not alpha particles." },
        { "answer": "It has a half-life of several years for extended monitoring", "explanation": "Its 6-hour half-life is short, reducing patient dose after imaging." },
        { "answer": "It naturally concentrates in all cancer cells", "explanation": "Tc-99m is attached to various compounds to target specific organs." }
      ]
    },
    {
      "type": "mc",
      "question": "How does the choice of half-life differ between diagnostic and therapeutic radioisotopes?",
      "correct": "Diagnostic isotopes need shorter half-lives; therapeutic isotopes may have longer half-lives",
      "correctExplanation": "Diagnostics minimise dose with short half-lives; therapy needs time to deliver treatment dose.",
      "distractors": [
        { "answer": "Both applications always use the same half-life range", "explanation": "Different applications have different requirements for radiation duration." },
        { "answer": "Therapeutic isotopes must have shorter half-lives than diagnostic ones", "explanation": "Therapy often uses longer half-lives to deliver sustained treatment." },
        { "answer": "Half-life is irrelevant for medical applications", "explanation": "Half-life is crucial for both minimising diagnostic exposure and optimising therapy." }
      ]
    },
    {
      "type": "mc",
      "question": "Why might iodine-131 (beta emitter) be more effective for thyroid cancer treatment than a gamma emitter?",
      "correct": "Beta particles deposit energy locally, concentrating dose in thyroid tissue",
      "correctExplanation": "Beta's short range delivers high dose to nearby cells while sparing distant tissues.",
      "distractors": [
        { "answer": "Beta particles travel further and treat more tissue", "explanation": "Beta particles have short range, which is beneficial for localised treatment." },
        { "answer": "Gamma emitters cannot be absorbed by the thyroid", "explanation": "The thyroid absorbs iodine regardless of what radiation it emits." },
        { "answer": "Beta particles can be detected externally for monitoring", "explanation": "External detection is easier with gamma; beta's advantage is therapeutic dose delivery." }
      ]
    },
    {
      "type": "mc",
      "question": "What is a PET scan and how does it use radioisotopes?",
      "correct": "It detects gamma rays from positron-emitting isotopes to create metabolic images",
      "correctExplanation": "Positrons annihilate with electrons, producing gamma rays that are detected to map metabolic activity.",
      "distractors": [
        { "answer": "It uses alpha particles to create detailed bone images", "explanation": "PET uses positron emitters, not alpha particles." },
        { "answer": "It measures beta radiation directly from organs", "explanation": "PET detects gamma rays from positron annihilation, not direct beta." },
        { "answer": "It uses stable isotopes that don't emit radiation", "explanation": "PET requires radioactive positron-emitting isotopes." }
      ]
    },
    {
      "type": "mc",
      "question": "How does external beam radiotherapy differ from brachytherapy?",
      "correct": "External beam uses radiation from outside; brachytherapy places sources inside or near the tumour",
      "correctExplanation": "External beam irradiates from outside the body; brachytherapy implants radioactive sources near the cancer.",
      "distractors": [
        { "answer": "External beam uses alpha particles; brachytherapy uses gamma", "explanation": "Both can use various radiation types; the difference is source location." },
        { "answer": "Brachytherapy is only for diagnosis, not treatment", "explanation": "Brachytherapy is a treatment method using implanted sources." },
        { "answer": "External beam cannot treat deep tumours", "explanation": "External beam can treat deep tumours; brachytherapy treats accessible ones internally." }
      ]
    },
    {
      "type": "mc",
      "question": "Why are radiopharmaceuticals designed to target specific organs or tissues?",
      "correct": "To concentrate radiation at the site of interest while minimising dose elsewhere",
      "correctExplanation": "Targeting increases effectiveness for imaging or therapy while reducing exposure to healthy tissues.",
      "distractors": [
        { "answer": "Because radiation cannot travel through the body", "explanation": "Gamma radiation travels through the body; targeting is about concentration, not transport." },
        { "answer": "To make the radioisotope easier to manufacture", "explanation": "Targeting is about medical effectiveness, not production." },
        { "answer": "Because all organs absorb radiation equally without targeting", "explanation": "Without targeting, distribution would be non-specific; targeting improves specificity." }
      ]
    },
    {
      "type": "tf",
      "question": "Beta-emitting isotopes are generally preferred for therapy because they deposit energy locally.",
      "correct": "True",
      "correctExplanation": "Beta particles' short range concentrates dose in target tissue, ideal for destroying cancer cells.",
      "distractors": [
        { "answer": "False", "explanation": "Students may think penetrating gamma is always better, but localised beta is often preferable for therapy." }
      ]
    },
    {
      "type": "cloze",
      "prompt": "Complete the explanation of PET imaging.",
      "sentence": "In PET scans, {{blank:1}} emitters are used, which produce gamma rays when positrons {{blank:2}} with electrons.",
      "blanks": {
        "1": {
          "correct": "positron",
          "correctExplanation": "PET (Positron Emission Tomography) uses positron-emitting isotopes.",
          "distractors": [
            { "answer": "alpha", "explanation": "PET uses positron emitters, not alpha emitters." },
            { "answer": "neutron", "explanation": "Neutron emitters are not used in PET scanning." }
          ]
        },
        "2": {
          "correct": "annihilate",
          "correctExplanation": "Positron-electron annihilation produces two gamma rays detected by the scanner.",
          "distractors": [
            { "answer": "combine", "explanation": "Annihilation is the specific process; combination is less precise." },
            { "answer": "repel", "explanation": "Positrons and electrons attract and annihilate, not repel." }
          ]
        }
      }
    },
    {
      "type": "cloze",
      "prompt": "Complete the comparison of treatment methods.",
      "sentence": "Brachytherapy places radioactive sources {{blank:1}} the tumour, while external beam delivers radiation from {{blank:2}} the body.",
      "blanks": {
        "1": {
          "correct": "inside",
          "correctExplanation": "Brachytherapy implants sources in or very near the tumour.",
          "distractors": [
            { "answer": "far from", "explanation": "Brachytherapy places sources close to or inside the tumour." },
            { "answer": "outside", "explanation": "External beam is from outside; brachytherapy is internal." }
          ]
        },
        "2": {
          "correct": "outside",
          "correctExplanation": "External beam radiotherapy directs radiation from machines outside the body.",
          "distractors": [
            { "answer": "inside", "explanation": "Internal placement describes brachytherapy, not external beam." },
            { "answer": "within", "explanation": "External beam comes from outside, not within the body." }
          ]
        }
      }
    },
    {
      "type": "cloze",
      "prompt": "Complete the statement about radiopharmaceutical design.",
      "sentence": "Radiopharmaceuticals are designed to {{blank:1}} in specific organs, maximising {{blank:2}} or treatment effectiveness while minimising whole-body dose.",
      "blanks": {
        "1": {
          "correct": "concentrate",
          "correctExplanation": "Targeting specific organs concentrates the radioisotope where it's needed.",
          "distractors": [
            { "answer": "disperse", "explanation": "Dispersion would reduce effectiveness; concentration is the goal." },
            { "answer": "dissolve", "explanation": "Dissolving is not the targeting mechanism; concentration is." }
          ]
        },
        "2": {
          "correct": "imaging",
          "correctExplanation": "Concentration improves image quality for diagnosis or dose delivery for therapy.",
          "distractors": [
            { "answer": "confusion", "explanation": "Clarity, not confusion, is the goal of targeting." },
            { "answer": "dispersion", "explanation": "Dispersion is the opposite of the targeting goal." }
          ]
        }
      }
    }
  ],
  "toLevel4": [
    {
      "type": "mc",
      "question": "A nuclear medicine department must choose between F-18 FDG (110 min half-life) and Tc-99m (6 hour half-life) for a scan. The patient lives 3 hours from the hospital. Which practical factor favours Tc-99m?",
      "correct": "Tc-99m's longer half-life allows more time for patient travel and preparation",
      "correctExplanation": "F-18's short half-life means significant decay during the 3-hour travel; Tc-99m retains more activity.",
      "distractors": [
        { "answer": "F-18 is always preferred due to better image quality", "explanation": "Both produce good images; logistics favour Tc-99m for this patient." },
        { "answer": "Tc-99m gives the patient less radiation dose", "explanation": "Dose depends on many factors; the question is about practical logistics." },
        { "answer": "F-18 can be produced at the local hospital", "explanation": "F-18 requires a cyclotron; Tc-99m is more widely available." }
      ]
    },
    {
      "type": "mc",
      "question": "A patient with differentiated thyroid cancer receives iodine-131 therapy. They are advised to stay away from pregnant women and children for several days. Explain the scientific basis for this advice.",
      "correct": "The patient emits gamma radiation that could expose nearby people externally",
      "correctExplanation": "I-131 also emits gamma rays that can irradiate people near the patient until the isotope decays.",
      "distractors": [
        { "answer": "The patient might spread radioactive iodine through direct contact", "explanation": "While contamination precautions apply, the main concern is external gamma exposure." },
        { "answer": "Children and pregnant women are immune to beta radiation only", "explanation": "They are more sensitive to radiation, not immune to any type." },
        { "answer": "The radioactivity can be transmitted through conversation", "explanation": "Radiation exposure decreases with distance, not through speech." }
      ]
    },
    {
      "type": "mc",
      "question": "Compare the radiation protection considerations for a patient undergoing a Tc-99m bone scan versus external beam radiotherapy for bone cancer.",
      "correct": "Bone scan delivers low whole-body dose; radiotherapy delivers high localised dose requiring treatment room shielding",
      "correctExplanation": "Diagnostic doses are much lower than therapeutic; radiotherapy rooms need heavy shielding.",
      "distractors": [
        { "answer": "Both procedures have identical radiation protection requirements", "explanation": "Therapeutic doses are much higher, requiring different safety measures." },
        { "answer": "Bone scans require more shielding because the isotope is inside the patient", "explanation": "Tc-99m doses are low; external beam therapy uses much higher radiation intensities." },
        { "answer": "External beam patients need isolation but scan patients don't", "explanation": "External beam patients aren't radioactive; internal isotope patients may need temporary precautions." }
      ]
    },
    {
      "type": "mc",
      "question": "A radiopharmaceutical company develops a new alpha-emitting treatment for prostate cancer metastases in bone. What property of alpha radiation makes this approach potentially effective?",
      "correct": "Alpha particles deposit high energy in a very small volume, destroying cancer cells precisely",
      "correctExplanation": "Alpha's short range and high LET deliver lethal doses to nearby cancer cells while sparing distant healthy tissue.",
      "distractors": [
        { "answer": "Alpha particles can travel through bone to reach all metastases", "explanation": "Alpha particles have very short range; they work because the isotope concentrates at metastases." },
        { "answer": "Alpha radiation is less damaging than beta, reducing side effects", "explanation": "Alpha is more damaging per dose, which is the therapeutic advantage." },
        { "answer": "Alpha emitters have longer half-lives for sustained treatment", "explanation": "Half-life varies; alpha's advantage is high local dose delivery." }
      ]
    },
    {
      "type": "mc",
      "question": "A hospital must decide between purchasing a SPECT scanner (uses gamma emitters like Tc-99m) or a PET scanner (uses positron emitters like F-18). What fundamental difference affects this decision?",
      "correct": "PET requires cyclotron-produced isotopes with short half-lives; SPECT uses generator-produced Tc-99m",
      "correctExplanation": "PET isotopes need nearby cyclotrons due to short half-lives; SPECT's Tc-99m is more widely available.",
      "distractors": [
        { "answer": "SPECT produces better image quality than PET in all cases", "explanation": "PET often provides superior metabolic imaging; the issue is isotope availability." },
        { "answer": "PET scanners are always less expensive than SPECT", "explanation": "PET is generally more expensive due to cyclotron requirements." },
        { "answer": "SPECT requires more patient radiation exposure than PET", "explanation": "Doses vary by procedure; the key difference is isotope production requirements." }
      ]
    },
    {
      "type": "mc",
      "question": "During radioiodine therapy, why might a doctor prescribe thyroid hormone supplements even though the goal is to destroy thyroid tissue?",
      "correct": "To suppress TSH, which stimulates thyroid tissue and could reduce treatment effectiveness",
      "correctExplanation": "Controlling thyroid stimulation optimises radioiodine uptake by cancer cells versus normal thyroid remnants.",
      "distractors": [
        { "answer": "To replace hormones the radioiodine will destroy", "explanation": "While replacement is eventually needed, the initial purpose is often TSH suppression for treatment optimisation." },
        { "answer": "Thyroid hormones block radiation damage to healthy tissue", "explanation": "Hormones don't block radiation; they affect thyroid tissue metabolism." },
        { "answer": "To increase the half-life of iodine-131", "explanation": "Half-life is a physical constant that cannot be changed by medications." }
      ]
    },
    {
      "type": "mc",
      "question": "A paediatric patient requires a nuclear medicine scan. How should the administered activity differ from an adult dose, and why?",
      "correct": "Lower activity is used because children are more radiosensitive and smaller",
      "correctExplanation": "Paediatric doses are scaled down based on body size and account for higher radiation sensitivity.",
      "distractors": [
        { "answer": "Higher activity is needed because children move more during scans", "explanation": "Movement is managed differently; dose reduction is standard for children." },
        { "answer": "The same activity is used because radiation affects all ages equally", "explanation": "Children are more radiosensitive, requiring dose adjustment." },
        { "answer": "No adjustment is needed as the isotope knows to avoid growing tissues", "explanation": "Isotopes don't discriminate; dose adjustment protects sensitive tissues." }
      ]
    },
    {
      "type": "cloze",
      "prompt": "Complete the comparison of imaging modalities.",
      "sentence": "SPECT imaging uses {{blank:1}}-produced isotopes like Tc-99m, while PET requires {{blank:2}}-produced positron emitters with shorter half-lives.",
      "blanks": {
        "1": {
          "correct": "generator",
          "correctExplanation": "Tc-99m comes from Mo-99/Tc-99m generators shipped to hospitals.",
          "distractors": [
            { "answer": "cyclotron", "explanation": "Cyclotrons produce PET isotopes; generators produce Tc-99m." },
            { "answer": "reactor", "explanation": "While Mo-99 comes from reactors, Tc-99m comes from generators at hospitals." }
          ]
        },
        "2": {
          "correct": "cyclotron",
          "correctExplanation": "PET isotopes like F-18 are produced in cyclotrons.",
          "distractors": [
            { "answer": "generator", "explanation": "Generators produce Tc-99m; cyclotrons produce PET isotopes." },
            { "answer": "natural", "explanation": "PET isotopes are artificially produced, not naturally occurring." }
          ]
        }
      }
    },
    {
      "type": "cloze",
      "prompt": "Complete the statement about alpha therapy.",
      "sentence": "Alpha-emitting treatments are effective for bone metastases because the {{blank:1}} range of alpha particles delivers {{blank:2}} dose precisely to cancer cells.",
      "blanks": {
        "1": {
          "correct": "short",
          "correctExplanation": "Alpha particles travel only micrometres to millimetres in tissue.",
          "distractors": [
            { "answer": "long", "explanation": "Alpha particles have very short range, which is why they're precise." },
            { "answer": "variable", "explanation": "Alpha range is consistently short in tissue." }
          ]
        },
        "2": {
          "correct": "high",
          "correctExplanation": "Alpha particles deposit large amounts of energy in small volumes.",
          "distractors": [
            { "answer": "low", "explanation": "Alpha deposits high energy, which is why it's effective for treatment." },
            { "answer": "no", "explanation": "Alpha particles do deposit dose; that's their therapeutic mechanism." }
          ]
        }
      }
    },
    {
      "type": "cloze",
      "prompt": "Complete the patient safety statement.",
      "sentence": "After radioiodine therapy, patients must temporarily avoid close contact with others because they emit {{blank:1}} radiation that could expose nearby people.",
      "blanks": {
        "1": {
          "correct": "gamma",
          "correctExplanation": "I-131 emits gamma rays in addition to beta, and gamma can expose others externally.",
          "distractors": [
            { "answer": "alpha", "explanation": "Alpha cannot exit the body; gamma is the external exposure concern." },
            { "answer": "neutron", "explanation": "I-131 does not emit neutrons; gamma is the concern." }
          ]
        }
      }
    }
  ],
  "toLevel5": [
    {
      "type": "mc",
      "question": "Evaluate the trade-off: A new radiopharmaceutical provides superior diagnostic images but has a 24-hour half-life compared to Tc-99m's 6 hours. Under what circumstances might the longer half-life be acceptable?",
      "correct": "When the diagnostic information significantly improves patient outcomes despite higher dose",
      "correctExplanation": "Medical decisions balance radiation risk against diagnostic benefit; superior information may justify higher dose.",
      "distractors": [
        { "answer": "Longer half-lives are never acceptable due to radiation protection principles", "explanation": "Risk-benefit analysis may favour longer half-lives if diagnostic value is high." },
        { "answer": "Only if the patient requests the newer procedure", "explanation": "Patient preference is one factor, but clinical benefit justifies the choice." },
        { "answer": "When the hospital needs to justify purchasing new equipment", "explanation": "Equipment decisions should be based on patient benefit, not procurement justification." }
      ]
    },
    {
      "type": "mc",
      "question": "A pharmaceutical company develops theranostic agents - radiopharmaceuticals that can be labelled with either diagnostic or therapeutic isotopes. Evaluate the advantages of this approach.",
      "correct": "The same targeting molecule confirms tumour uptake before delivering therapeutic doses",
      "correctExplanation": "Theranostics allows imaging to verify targeting before committing to therapy, personalising treatment.",
      "distractors": [
        { "answer": "It eliminates all radiation exposure from cancer treatment", "explanation": "Radiation is still used; theranostics optimises its use, not eliminates it." },
        { "answer": "Therapeutic and diagnostic isotopes are interchangeable", "explanation": "Different isotopes have different properties; the targeting molecule is what's shared." },
        { "answer": "It reduces the cost of radiopharmaceutical production", "explanation": "Cost may or may not decrease; the main advantage is personalised medicine." }
      ]
    },
    {
      "type": "mc",
      "question": "Analyse why some cancer patients receive multiple fractions of external beam radiotherapy rather than a single large dose, while radioiodine therapy is often given as a single administration.",
      "correct": "External beam affects healthy tissue in the beam path; radioiodine selectively concentrates in thyroid tissue",
      "correctExplanation": "Fractionation spares healthy tissue in the beam path; radioiodine's selectivity allows single dosing.",
      "distractors": [
        { "answer": "External beam equipment can only deliver small doses at a time", "explanation": "Equipment can deliver large doses; fractionation is a biological strategy." },
        { "answer": "Radioiodine works instantly while external beam needs time", "explanation": "Both cause cell damage over time; the difference is targeting selectivity." },
        { "answer": "Multiple fractions always produce better outcomes than single doses", "explanation": "The optimal approach depends on the treatment's selectivity for cancer versus healthy tissue." }
      ]
    },
    {
      "type": "mc",
      "question": "A patient with metastatic neuroendocrine cancer is offered Lu-177 DOTATATE therapy. The treatment involves injecting a radioactive molecule that binds to receptors on the cancer cells. Evaluate why this targeted approach may be superior to external beam for this condition.",
      "correct": "Metastases throughout the body can all be treated simultaneously with systemic administration",
      "correctExplanation": "External beam treats local areas; systemic radioligand therapy reaches metastases wherever they are.",
      "distractors": [
        { "answer": "Lu-177 eliminates all cancer cells instantly upon injection", "explanation": "Treatment works over time; the advantage is reaching widespread metastases." },
        { "answer": "External beam cannot kill neuroendocrine cancer cells", "explanation": "External beam can treat these cancers; the issue is reaching multiple metastatic sites." },
        { "answer": "Targeted therapy has zero side effects unlike external beam", "explanation": "All radiation therapies have potential side effects; targeting improves the therapeutic ratio." }
      ]
    },
    {
      "type": "mc",
      "question": "Compare the radiation protection challenges of a PET-CT department versus a nuclear medicine therapy ward. How do the sources and durations of exposure differ?",
      "correct": "PET-CT has brief high-activity patients; therapy wards have lower-activity patients for extended stays",
      "correctExplanation": "PET isotopes decay quickly but patients are highly active initially; therapy patients emit radiation for days.",
      "distractors": [
        { "answer": "PET-CT departments have no radiation exposure concerns", "explanation": "PET patients are significant radiation sources, requiring staff protection." },
        { "answer": "Therapy wards have higher instantaneous dose rates than PET-CT", "explanation": "PET patients often have higher initial activity; therapy involves longer duration exposure." },
        { "answer": "Both departments face identical radiation protection challenges", "explanation": "The temporal pattern of exposure differs significantly between these settings." }
      ]
    },
    {
      "type": "mc",
      "question": "A health technology assessment must compare the cost-effectiveness of Ga-68 PSMA PET (cyclotron-produced, 68 min half-life) versus Tc-99m PSMA SPECT (generator-produced, 6 hr half-life) for prostate cancer staging. What factors beyond image quality should be considered?",
      "correct": "Infrastructure requirements, isotope availability, patient throughput, and total healthcare system costs",
      "correctExplanation": "Cyclotron access, scheduling constraints from short half-life, and operational costs affect overall value.",
      "distractors": [
        { "answer": "Only image quality and patient radiation dose should be considered", "explanation": "Cost-effectiveness includes operational and infrastructure considerations." },
        { "answer": "Newer technology is always more cost-effective", "explanation": "Newer isn't automatically better value; systematic assessment is needed." },
        { "answer": "Generator systems are always inferior to cyclotron-based imaging", "explanation": "Each has advantages; assessment should consider the specific clinical context." }
      ]
    },
    {
      "type": "mc",
      "question": "Emerging alpha-particle therapies like Ac-225 show promise for treating micrometastases. However, Ac-225 decays through multiple daughters, some of which may redistribute in the body. Evaluate the implications for treatment planning.",
      "correct": "Daughter redistribution could deliver unintended dose to healthy organs, complicating dosimetry",
      "correctExplanation": "Decay chain products may not stay at the target site, potentially causing off-target radiation effects.",
      "distractors": [
        { "answer": "Daughter isotopes always remain at the original tumour site", "explanation": "Daughters may have different chemical properties and redistribute." },
        { "answer": "Alpha emitter decay chains make treatment impossible", "explanation": "Challenges exist but don't preclude treatment; they require careful planning." },
        { "answer": "Redistribution only affects imaging, not therapy", "explanation": "Redistribution affects where therapeutic dose is delivered." }
      ]
    },
    {
      "type": "mc",
      "question": "A regulatory body is developing guidelines for releasing radioiodine therapy patients from hospital. What scientific and practical factors should inform the dose rate threshold at which patients can go home?",
      "correct": "Predicted dose to family members, patient living situation, ability to follow precautions, and decay kinetics",
      "correctExplanation": "Release criteria balance radiation protection for contacts against practical and psychological benefits of going home.",
      "distractors": [
        { "answer": "Patients should remain hospitalised until all radioactivity has decayed", "explanation": "This is impractical and unnecessary; risk-based thresholds allow earlier release." },
        { "answer": "Only the patient's measured dose rate matters for release decisions", "explanation": "Living situation and ability to minimise contact with others are also relevant." },
        { "answer": "Release criteria should be identical for all patients regardless of circumstances", "explanation": "Individual circumstances affect the risk to others and can inform release decisions." }
      ]
    },
    {
      "type": "cloze",
      "prompt": "Complete the analysis of theranostic approaches.",
      "sentence": "Theranostic radiopharmaceuticals allow {{blank:1}} imaging to verify tumour uptake before administering {{blank:2}} doses, personalising cancer treatment.",
      "blanks": {
        "1": {
          "correct": "diagnostic",
          "correctExplanation": "Initial diagnostic imaging confirms the targeting molecule reaches the tumour.",
          "distractors": [
            { "answer": "therapeutic", "explanation": "Diagnosis comes first to verify targeting before therapy." },
            { "answer": "anatomical", "explanation": "Functional/molecular imaging with the theranostic agent is the key step." }
          ]
        },
        "2": {
          "correct": "therapeutic",
          "correctExplanation": "After confirming uptake, therapeutic isotopes are used with the same targeting molecule.",
          "distractors": [
            { "answer": "diagnostic", "explanation": "Therapy follows diagnosis in the theranostic approach." },
            { "answer": "minimal", "explanation": "Therapeutic doses are significant, not minimal." }
          ]
        }
      }
    },
    {
      "type": "cloze",
      "prompt": "Complete the statement about systemic radiotherapy advantages.",
      "sentence": "Systemic radioligand therapy can treat {{blank:1}} metastases throughout the body simultaneously, unlike external beam which treats {{blank:2}} areas.",
      "blanks": {
        "1": {
          "correct": "multiple",
          "correctExplanation": "Systemic administration reaches metastases wherever they occur in the body.",
          "distractors": [
            { "answer": "single", "explanation": "The advantage is treating multiple sites, not just one." },
            { "answer": "no", "explanation": "Systemic therapy does treat metastases effectively." }
          ]
        },
        "2": {
          "correct": "localised",
          "correctExplanation": "External beam must be aimed at specific known tumour locations.",
          "distractors": [
            { "answer": "all", "explanation": "External beam treats targeted areas, not the whole body." },
            { "answer": "microscopic", "explanation": "External beam treats defined volumes, which may include microscopic disease but requires targeting." }
          ]
        }
      }
    }
  ]
}
